These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11241787)

  • 21. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
    Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
    Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
    Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia.
    Pakakasama S; Kajanachumpol S; Kanjanapongkul S; Sirachainan N; Meekaewkunchorn A; Ningsanond V; Hongeng S
    Int J Lab Hematol; 2008 Aug; 30(4):286-91. PubMed ID: 18665825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
    Van der Reijden BA; de Wit L; van der Poel S; Luiten EB; Lafage-Pochitaloff M; Dastugue N; Gabert J; Löwenberg B; Jansen JH
    Hematol J; 2001; 2(3):206-9. PubMed ID: 11920247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of residual disease in acute leukemia by means of polymerase chain reaction.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Pérez-Romano B; Ruiz-Argüelles A; Ramírez-Cisneros FJ; López-Martínez B; López-Tapia JD; Rivadeneyra-Espinoza L
    Rev Invest Clin; 2000; 52(2):118-24. PubMed ID: 10846434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.
    Hernández JM; González MB; Granada I; Gutiérrez N; Chillón C; Ramos F; Ribera JM; González M; Feliu E; San Miguel J
    Haematologica; 2000 May; 85(5):481-5. PubMed ID: 10800163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term disease-free acute myeloblastic leukemia with inv(16) is associated with PCR undetectable CBFbeta/MYH11 transcript.
    Martinelli G; Ottaviani E; Testoni N; Montefusco V; Pastano R; Tura S
    Haematologica; 2000 May; 85(5):552-5. PubMed ID: 10800179
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia.
    Corbacioglu A; Scholl C; Schlenk RF; Eiwen K; Du J; Bullinger L; Fröhling S; Reimer P; Rummel M; Derigs HG; Nachbaur D; Krauter J; Ganser A; Döhner H; Döhner K
    J Clin Oncol; 2010 Aug; 28(23):3724-9. PubMed ID: 20625124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
    Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
    Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
    Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
    Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
    Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
    Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
    Tobal K; Frost L; Liu Yin JA
    Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment of a new method for screening of CBFB-MYH11 fusion gene in acute myeloid leukemia and its value in clinical use].
    Chen C; Li ZP; Lu QY; Liu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1077-81. PubMed ID: 23114122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gene product of CBFB-MYH11.
    Claxton D; Xie QS; Patel S; Deisseroth AB; Kornblau S
    Leukemia; 1996 Sep; 10(9):1479-85. PubMed ID: 8751466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.
    Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F
    Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
    Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
    Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.